FEMSelect: FEMSelect Raises US$9M in Series B Financing

FemSelect, a Tel Aviv, Israel-based developer of an innovative approach to pelvic floor ligament fixation, raised US$9M in Series B funding. The round was led by New Age Ventures, and TriVentures, with participation from Robin Hood Ventures, Mid Atlantic Bio Angels, MEDA Angels, Keiretsu Forum Mid-Atlantic, RAD BioMed, Keiretsu Capital and Transpacific Venture Partners. Following its [...]The post FEMSelect Raises US$9M in Series B Financing appeared first on FinSMEs.